GO:0019842 vitamin binding: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0019842 vitamin binding is a molecular function defined as binding to a vitamin, an organic micronutrient required in trace amounts for normal metabolism.
• Major vitamin-binding proteins include vitamin D-binding protein (GC), retinol-binding protein 4 (RBP4), and intracellular receptors such as VDR and RARA/RXRA [1,4].
• Vitamin D-binding protein (DBP/GC) transports vitamin D metabolites and is implicated in chronic liver disease, hyperglycaemia, and immune regulation [1,5,6].
• Retinol-binding protein 4 (RBP4) and cellular retinol-binding proteins mediate vitamin A signaling and homeostasis, linking to obesity and diabetes.
• Vitamin-binding proteins are essential for embryonic nutrition and development, as shown in avian models.
• Dysregulated vitamin binding can contribute to neurotoxicity and metabolic disorders, making these proteins key research targets.
Description
Vitamin binding (GO:0019842) is a molecular function that enables a protein to selectively bind one of a number of unrelated organic substances classified as vitamins, which are required in trace amounts for normal metabolic functioning of the body. This function is fundamental to vitamin transport, cellular uptake, and signal transduction, as vitamins cannot be synthesized endogenously in sufficient quantities and must be obtained from the diet. Understanding vitamin binding is therefore critical for elucidating how organisms maintain vitamin homeostasis and respond to deficiency or excess. Research on vitamin-binding proteins has revealed their roles in diverse physiological processes, including calcium homeostasis, immune modulation, and embryonic development [3,8]. For example, vitamin D-binding protein (DBP) binds vitamin D metabolites and facilitates their transport to target tissues, while retinol-binding protein 4 (RBP4) carries vitamin A derivatives in circulation [1,4]. These proteins are not merely passive carriers; they influence vitamin bioavailability, receptor interactions, and downstream signaling [2,5]. Consequently, vitamin binding is a focal point for studies on metabolic disorders, chronic liver diseases, and neurotoxicity [1,6,7]. The molecular function GO:0019842 encompasses all proteins capable of binding vitamins, including enzymes, transporters, and nuclear receptors, making it a broad yet essential category in molecular biology.
vitamin binding At A Glance
| GO ID | GO:0019842 |
|---|---|
| GO term | vitamin binding |
| Ontology | molecular_function |
| Synonym | none |
| Definition | Binding to a vitamin, one of a number of unrelated organic substances that occur in many foods in small amounts and that are necessary in trace amounts for the normal metabolic functioning of the body. |
| Major function | Transport, storage, and cellular delivery of vitamins; modulation of vitamin-dependent signaling. |
| Examples of gene products | GC (vitamin D-binding protein), RBP4 (retinol-binding protein 4), VDR (vitamin D receptor), RARA (retinoic acid receptor alpha). |
| Related diseases | Chronic liver disease, hyperglycaemia, obesity, diabetes, vitamin neurotoxicity. |
| Research relevance | Target for metabolic, nutritional, and developmental studies; biomarker potential in disease. |
What Is GO:0019842?
According to the Gene Ontology, GO:0019842 vitamin binding is defined as the binding to a vitamin, which is one of a number of unrelated organic substances that occur in many foods in small amounts and are necessary in trace amounts for the normal metabolic functioning of the body. In other words, it describes the molecular function of any protein that physically interacts with a vitamin molecule, whether for transport, storage, enzymatic catalysis, or signal transduction. This term does not specify a particular vitamin; it covers binding to all vitamins, including fat-soluble (A, D, E, K) and water-soluble (B-complex, C) vitamins. The function is typically mediated by specific structural domains that recognize the vitamin's chemical structure, such as the vitamin D-binding domain in DBP or the retinol-binding pocket in RBP4 [1,4].
Why Is vitamin binding Important in Cell Biology?
Vitamin binding is essential for understanding how organisms acquire, distribute, and utilize vitamins, which are indispensable for normal metabolism. Dysregulation of vitamin-binding proteins is linked to a wide range of pathologies, including chronic liver diseases, metabolic disorders such as obesity and diabetes, and neurotoxicity [1,4,7]. Moreover, vitamin-binding proteins influence the bioavailability of vitamins and their interaction with nuclear receptors, thereby affecting gene expression and cellular responses [2,3]. Studying GO:0019842 therefore provides insights into nutritional biochemistry, endocrinology, and disease mechanisms, and it supports the development of biomarkers and therapeutic strategies targeting vitamin homeostasis [5,6].
• Vitamin binding enables the transport of fat-soluble vitamins in aqueous environments, such as vitamin D by DBP.
• It facilitates cellular uptake and intracellular delivery of vitamins to specific compartments.
• Vitamin-binding proteins modulate the activity of nuclear receptors like VDR and RAR, influencing gene expression [3,4].
• They are critical for embryonic development and nutrition, as demonstrated in avian models.
• Altered vitamin binding is associated with chronic liver diseases and hyperglycaemia [1,6].
• Vitamin A-binding proteins like RBP4 are linked to obesity, insulin resistance, and diabetes.
• Excessive vitamin binding or dysregulation can lead to neurotoxicity.
• Analytical challenges in measuring vitamin D metabolites highlight the importance of binding proteins in clinical diagnostics.
• Vitamin D-binding protein polymorphisms may affect individual responses to vitamin D supplementation.
• Understanding vitamin binding aids in designing targeted therapies for metabolic and nutritional disorders.
Molecular Mechanism of vitamin binding
Substrate Recognition and Binding Pocket
In simple terms: The protein has a specially shaped pocket that fits a specific vitamin like a lock and key.
Vitamin-binding proteins possess structural domains that recognize the unique chemical structure of a vitamin. For example, vitamin D-binding protein (DBP) binds vitamin D metabolites with high affinity through a specific binding pocket, enabling transport in circulation. Similarly, retinol-binding protein 4 (RBP4) binds retinol, facilitating its delivery to target tissues. The binding specificity is determined by amino acid residues that form hydrogen bonds and hydrophobic interactions with the vitamin. This recognition is crucial for preventing degradation and ensuring targeted delivery.
Transport and Delivery
In simple terms: After binding, the protein carries the vitamin through the bloodstream to where it is needed.
Once bound, vitamin-binding proteins act as carriers. DBP transports vitamin D and its metabolites to target cells, where the complex interacts with receptors such as megalin for cellular uptake. RBP4 transports retinol from the liver to peripheral tissues, and its release is regulated by nutritional status. In avian embryos, vitamin-binding proteins in egg yolk deliver vitamins to the developing embryo, highlighting their role in nutrition. This transport function is essential for maintaining vitamin homeostasis and preventing deficiency.
Cellular Uptake and Intracellular Handling
In simple terms: Cells take in the vitamin-protein complex and release the vitamin inside for use.
Cellular uptake of vitamin-bound proteins often involves receptor-mediated endocytosis. For vitamin D, the DBP-megalin complex is internalized, and vitamin D is released intracellularly to interact with the vitamin D receptor (VDR). Inside the cell, vitamin A derivatives bind to cellular retinol-binding proteins (CRBPs) and retinoic acid-binding proteins (CRABPs), which direct them to nuclear receptors like RAR and RXR. This intracellular handling ensures that vitamins reach their site of action and participate in metabolic pathways.
Regulation of Vitamin Binding
In simple terms: The amount of vitamin-binding proteins can go up or down based on the body's needs.
The expression and activity of vitamin-binding proteins are regulated by various factors, including vitamin status, hormones, and metabolic signals. For instance, DBP levels are influenced by liver function and estrogen, and its polymorphisms affect vitamin D status. RBP4 secretion from adipocytes is linked to insulin resistance, and its levels correlate with obesity and diabetes. In avian embryos, vitamin-binding protein expression is developmentally regulated to meet the embryo's nutritional demands. This regulation ensures that vitamin binding is adapted to physiological needs.
Vitamin Binding in Disease and Toxicity
In simple terms: When vitamin binding goes wrong, it can contribute to diseases or even nerve damage.
Dysregulated vitamin binding is implicated in several pathologies. In chronic liver diseases, altered DBP levels affect vitamin D metabolism and immune function. Hyperglycaemia is associated with changes in DBP and VDR polymorphisms, impacting vitamin D signaling. Excessive vitamin A or its derivatives can cause neurotoxicity, partly due to overwhelming binding capacities. These examples underscore the clinical importance of vitamin-binding proteins.
Key Genes Involved in GO:0019842 vitamin binding
The following genes encode proteins that exhibit vitamin binding activity (GO:0019842) and are supported by published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| GC | Vitamin D-binding protein; transports vitamin D metabolites | Biomarker in liver disease, hyperglycaemia; polymorphisms affect vitamin D status [1,6] |
| RBP4 | Retinol-binding protein 4; transports vitamin A | Linked to obesity, insulin resistance, diabetes |
| VDR | Vitamin D receptor; binds vitamin D and mediates gene regulation | Polymorphisms associated with hyperglycaemia; target in calcium homeostasis [3,6] |
| RARA | Retinoic acid receptor alpha; binds retinoic acid | Mediates vitamin A signaling in development and differentiation |
| RARB | Retinoic acid receptor beta; binds retinoic acid | Involved in growth and differentiation; potential tumor suppressor |
| RARG | Retinoic acid receptor gamma; binds retinoic acid | Regulates skin and skeletal development |
| RXRA | Retinoid X receptor alpha; binds 9-cis retinoic acid | Heterodimer partner for VDR and RAR; central to nuclear receptor signaling [3,4] |
| RXRB | Retinoid X receptor beta; binds 9-cis retinoic acid | Modulates vitamin D and A signaling |
| RXRG | Retinoid X receptor gamma; binds 9-cis retinoic acid | Tissue-specific roles in vitamin signaling |
| CRBP1 | Cellular retinol-binding protein 1; binds retinol | Intracellular transport of vitamin A; affects retinoid metabolism |
| CRBP2 | Cellular retinol-binding protein 2; binds retinol | Enterocyte-specific; involved in vitamin A absorption |
| CRABP1 | Cellular retinoic acid-binding protein 1; binds retinoic acid | Modulates retinoic acid availability |
| CRABP2 | Cellular retinoic acid-binding protein 2; binds retinoic acid | Delivers retinoic acid to nuclear receptors |
| TTR | Transthyretin; binds retinol-binding protein 4 | Forms complex with RBP4 to prevent renal loss |
| CUBN | Cubilin; receptor for DBP-vitamin D complex | Mediates uptake of vitamin D in kidney |
| LRP2 | Megalin; receptor for DBP-vitamin D complex | Endocytic receptor for vitamin D uptake |
| ALB | Albumin; binds various vitamins with low affinity | Contributes to vitamin transport in plasma |
How Is vitamin binding Regulated?
The vitamin binding function is regulated at multiple levels. Expression of vitamin-binding proteins such as DBP and RBP4 is modulated by nutritional status, hormones, and metabolic signals. For instance, DBP synthesis in the liver is influenced by estrogen and liver function, and its polymorphisms affect vitamin D status. RBP4 secretion from adipocytes is linked to insulin resistance and obesity, and its levels are altered in diabetes. In avian embryos, vitamin-binding protein expression is developmentally regulated to meet nutritional demands. Additionally, the binding affinity and specificity can be affected by post-translational modifications and the presence of competing ligands. These regulatory mechanisms ensure that vitamin binding is adapted to physiological needs and can be disrupted in disease states.
vitamin binding and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| GC | Chronic liver disease; vitamin D deficiency | Liver-specific GC knockout mice; hepatocyte cell lines |
| RBP4 | Obesity, insulin resistance, type 2 diabetes | RBP4 knockout and transgenic mice; adipocyte cultures |
| VDR | Hyperglycaemia; calcium homeostasis | VDR knockout mice; pancreatic beta-cell lines |
| RARA | Developmental disorders; cancer | RARA knockout mice; leukemia cell lines |
| CRABP1 | Neurotoxicity; retinoic acid signaling | CRABP1 knockout mice; neuronal cultures |
Vitamin D Binding Protein in Chronic Liver Diseases
Vitamin D-binding protein (DBP/GC) plays a critical role in vitamin D transport and immune modulation. In chronic liver diseases, reduced DBP levels are associated with vitamin D deficiency and disease progression. DBP polymorphisms have been linked to variations in vitamin D status and outcomes in liver disease patients. Research has shown that DBP can modulate immune cell function and may serve as a biomarker for liver disease severity.
Vitamin A Binding Proteins in Metabolic Disorders
Retinol-binding protein 4 (RBP4) is a major carrier of vitamin A in the blood. Elevated RBP4 levels are associated with obesity, insulin resistance, and type 2 diabetes. Studies suggest that RBP4 contributes to systemic insulin resistance by affecting glucose uptake in muscle and liver. Targeting RBP4 or its binding to retinol may offer therapeutic avenues for metabolic disorders.
Vitamin D Binding and Hyperglycaemia
Vitamin D-binding protein (DBP) and vitamin D receptor (VDR) polymorphisms have been implicated in hyperglycaemia and diabetes risk. Individuals with certain DBP variants may have altered vitamin D bioavailability, affecting glucose metabolism. Research indicates that DBP levels and VDR polymorphisms interact to influence insulin sensitivity and secretion. These findings highlight the importance of vitamin D binding in metabolic health.
Vitamin Neurotoxicity
Excessive intake of certain vitamins, particularly vitamin A and its derivatives, can lead to neurotoxicity. This is partly due to the saturation of vitamin-binding proteins, leading to free vitamin levels that can damage neurons. Understanding the binding capacity of proteins like RBP4 and CRABPs is essential for assessing the risk of vitamin neurotoxicity.
From vitamin binding-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of GC affect vitamin D transport and liver function? | GC knockout mouse (whole-body or liver-specific) |
| How does RBP4 overexpression impact insulin sensitivity? | RBP4 transgenic mouse or overexpression in adipocytes |
| What is the effect of a VDR point mutation on vitamin D signaling? | VDR point-mutation knock-in mouse (e.g., VDR-KO with human mutant VDR) |
| Can tagged DBP be used to track vitamin D distribution? | Knock-in mouse expressing FLAG-tagged DBP |
| Does CRABP1 deficiency alter retinoic acid neurotoxicity? | CRABP1 knockout mouse; primary neuronal cultures |
| What is the role of RARA in development? | RARA knockout and conditional knock-in mouse models |
How to Study the vitamin binding Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Surface plasmon resonance (SPR) | Binding affinity and kinetics | Characterizing DBP-vitamin D interaction |
| Isothermal titration calorimetry (ITC) | Thermodynamics of binding | Quantifying RBP4-retinol binding |
| CRISPR knockout | Loss-of-function effects | Studying GC role in vitamin D transport |
| RNA-seq | Transcriptional changes | Identifying VDR target genes |
| LC-MS/MS proteomics | Protein identification and quantification | Discovering novel vitamin-binding proteins |
| Fluorescence microscopy | Cellular localization and dynamics | Tracking vitamin D uptake via DBP |
| X-ray crystallography | 3D structure of binding pocket | Structural analysis of DBP |
| GWAS | Genetic associations | Linking GC polymorphisms to vitamin D status |
Biochemical Binding Assays
Direct measurement of vitamin binding can be performed using equilibrium dialysis, surface plasmon resonance (SPR), or isothermal titration calorimetry (ITC). These methods determine binding affinity (Kd) and specificity of proteins for vitamins. For example, SPR has been used to characterize the interaction between DBP and vitamin D metabolites. Such assays are essential for validating candidate vitamin-binding proteins identified through genomics or proteomics.
Genetic and Genomic Approaches
CRISPR-Cas9 knockout, knock-in, and point-mutation models enable functional studies of vitamin-binding genes. RNA sequencing (RNA-seq) can reveal transcriptional changes upon vitamin binding or deficiency. For instance, RNA-seq of VDR knockout cells has identified vitamin D target genes. Genome-wide association studies (GWAS) have linked polymorphisms in GC and VDR to vitamin D status and disease.
Proteomic and Structural Methods
Mass spectrometry-based proteomics can identify vitamin-binding proteins in complex mixtures. Affinity purification using vitamin-conjugated beads followed by LC-MS/MS is a powerful approach. Structural studies using X-ray crystallography or cryo-EM provide atomic-level insights into binding pockets, as seen for DBP and RBP4 [1,4]. These methods help elucidate the molecular basis of vitamin recognition.
Imaging and Cellular Assays
Fluorescence microscopy with fluorescently labeled vitamins or proteins can track vitamin uptake and intracellular trafficking. For example, fluorescent vitamin D analogs have been used to visualize DBP-mediated delivery. Live-cell imaging of GFP-tagged RBP4 has revealed its secretion dynamics. These techniques complement biochemical and genetic approaches.
How CRISPR Can Be Used to Study GO:0019842 vitamin binding
Knockout
CRISPR-Cas9 knockout of vitamin-binding genes such as GC or RBP4 allows researchers to study the consequences of loss of function. For example, GC knockout mice exhibit altered vitamin D transport and immune function. Knockout cell lines can be used to assess vitamin uptake and downstream signaling. This approach is fundamental for establishing causality in vitamin binding-related phenotypes.
Point Mutation
Introducing specific point mutations in vitamin-binding genes can mimic human polymorphisms or disrupt key binding residues. For instance, point mutations in VDR that affect ligand binding have been generated to study vitamin D resistance. Similarly, mutations in RBP4 can alter retinol binding affinity and secretion. These models provide insights into structure-function relationships and disease mechanisms.
Knock-in
Knock-in of tagged or humanized versions of vitamin-binding proteins enables tracking and functional studies. For example, knocking in a FLAG-tagged DBP allows immunoprecipitation and localization studies. Knock-in of human VDR into mouse models facilitates testing of human-specific vitamin D analogs. This approach is valuable for translational research.
Overexpression
Overexpression of vitamin-binding proteins such as RBP4 in adipocytes or transgenic mice can model elevated levels seen in obesity and diabetes. Overexpression of DBP in liver cells can enhance vitamin D transport and modulate immune responses. These models help elucidate the effects of excess vitamin binding in disease.
How EDITGENE Supports vitamin binding Research
Researchers studying vitamin binding-related genes often need to determine whether a candidate gene is causally involved in vitamin transport, signaling, or disease. EDITGENE provides comprehensive CRISPR gene editing services to create precisely tailored cell and animal models, enabling rigorous functional validation of vitamin-binding proteins.
Contact EDITGENE today to design your custom CRISPR model for vitamin binding research.
Related Products
| Product name | Cat.No. | Species | Gene ID | |
|---|---|---|---|---|
| GGCX Knockout HEK293 Cell Line | EDJ-KQ4703 | Human | 2677 | Details Get a Quote |
| PYGL Knockout HEK293 Cell Line | EDJ-KQ5618 | Human | 5836 | Details Get a Quote |
| PYGL Knockout A-549 Cell Line | EDJ-KQ28919 | Human | 5836 | Details Get a Quote |
| PYGL Knockout HCT 116 Cell Line | EDJ-KQ28920 | Human | 5836 | Details Get a Quote |
| PYGL Knockout HeLa Cell Line | EDJ-KQ28921 | Human | 5836 | Details Get a Quote |
| GGCX Knockout A-549 Cell Line | EDJ-KQ27414 | Human | 2677 | Details Get a Quote |
| GGCX Knockout HCT 116 Cell Line | EDJ-KQ27415 | Human | 2677 | Details Get a Quote |
| GGCX Knockout HeLa Cell Line | EDJ-KQ27416 | Human | 2677 | Details Get a Quote |
| PANK3 Knockout HEK293 Cell Line | EDJ-KQ51688 | Human | 79646 | Details Get a Quote |
| PANK3 Knockout HeLa Cell Line | EDJ-KQ57198 | Human | 79646 | Details Get a Quote |
| PANK3 Knockout A-549 Cell Line | EDJ-KQ65710 | Human | 79646 | Details Get a Quote |
| PANK3 Knockout HCT 116 Cell Line | EDJ-KQ74130 | Human | 79646 | Details Get a Quote |
Frequently Asked Questions About vitamin binding
What is vitamin binding (GO:0019842)?
Vitamin binding is a molecular function defined by the Gene Ontology as binding to a vitamin, an organic substance required in trace amounts for normal metabolism. It encompasses proteins that transport, store, or sense vitamins.
What genes are involved in vitamin binding?
Key genes include GC (vitamin D-binding protein), RBP4 (retinol-binding protein 4), VDR (vitamin D receptor), and RARA (retinoic acid receptor alpha), among others [1,4].
How does vitamin D-binding protein work?
Vitamin D-binding protein (DBP/GC) binds vitamin D metabolites and transports them in the bloodstream to target tissues, where the complex is internalized via receptors like megalin.
What diseases are associated with vitamin binding?
Dysregulated vitamin binding is linked to chronic liver diseases, hyperglycaemia, obesity, diabetes, and vitamin neurotoxicity [1,4,6,7].
What is the role of retinol-binding protein 4?
RBP4 transports vitamin A (retinol) from the liver to peripheral tissues. Elevated RBP4 levels are associated with insulin resistance and type 2 diabetes.
How can I study vitamin binding using CRISPR?
CRISPR knockout, point mutation, knock-in, and overexpression models allow functional studies of vitamin-binding genes. EDITGENE provides these services [1,3,4].
What methods are used to measure vitamin binding?
Common methods include surface plasmon resonance, isothermal titration calorimetry, and fluorescence-based assays to determine binding affinity and specificity.
Is vitamin binding related to neurotoxicity?
Yes, excessive vitamin A and its derivatives can saturate binding proteins, leading to free vitamin levels that may cause neurotoxicity.
What are the analytical challenges in vitamin D metabolite measurement?
Vitamin D metabolites are present at low concentrations and bind to proteins like DBP, requiring sensitive and specific assays such as LC-MS/MS.
Why is vitamin binding important for embryonic development?
Vitamin-binding proteins in egg yolk deliver vitamins to the developing embryo, as shown in avian models, highlighting their essential role in nutrition and development.
Conclusion
Vitamin binding (GO:0019842) is a fundamental molecular function that ensures the transport, delivery, and cellular utilization of vitamins, which are indispensable for normal metabolism. Proteins such as DBP, RBP4, and nuclear receptors like VDR and RAR mediate these processes and are implicated in a range of diseases, including chronic liver disease, metabolic disorders, and neurotoxicity. Understanding the mechanisms and regulation of vitamin binding provides critical insights into nutritional biochemistry and disease pathogenesis. With advanced CRISPR models and bioinformatics services from EDITGENE, researchers can dissect the roles of vitamin-binding proteins and develop targeted interventions.
References
- 1. Pop TL et al.. 2022. The Role of Vitamin D and Vitamin D Binding Protein in Chronic Liver Diseases.. Int J Mol Sci 23(18) PMID: 36142636
- 2. Alonso N et al.. 2023. Vitamin D Metabolites: Analytical Challenges and Clinical Relevance.. Calcif Tissue Int 112(2):158-177 PMID: 35238975
- 3. Fleet JC. 2022. Vitamin D-Mediated Regulation of Intestinal Calcium Absorption.. Nutrients 14(16) PMID: 36014856
- 4. Blaner WS. 2019. Vitamin A signaling and homeostasis in obesity, diabetes, and metabolic disorders.. Pharmacol Ther 197:153-178 PMID: 30703416
- 5. Delrue C et al.. 2023. Vitamin D and Vitamin D Binding Protein in Health and Disease 2.0.. Int J Mol Sci 24(12) PMID: 37373463
- 6. Erasmus R et al.. 2022. Vitamin D, Vitamin D-Binding Proteins, and VDR Polymorphisms in Individuals with Hyperglycaemia.. Nutrients 14(15) PMID: 35956323
- 7. Snodgrass SR. 1992. Vitamin neurotoxicity.. Mol Neurobiol 6(1):41-73 PMID: 1463588
- 8. White HB 3rd. 1987. Vitamin-binding proteins in the nutrition of the avian embryo.. J Exp Zool Suppl 1:53-63 PMID: 3298537
